Načítá se...
Pediatric drug development in Japan: Current issues and perspectives
The number of clinical trials in Japan that aim to obtain regulatory approval for new drugs and devices has increased for adults, but not children. The following reasons have been proposed for this discrepancy: the wide range of ages from newborns to adolescents, requirements for many drug formulati...
Uloženo v:
| Vydáno v: | Clin Pediatr Endocrinol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Japanese Society for Pediatric Endocrinology
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6958521/ https://ncbi.nlm.nih.gov/pubmed/32029968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.29.1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|